Share This Page
Drug Price Trends for NDC 42291-0183
✉ Email this page to a colleague
Average Pharmacy Cost for 42291-0183
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| No data available in table | ||||
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 42291-0183
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| BUPROPION HCL 300MG 24HR TAB,SA | AvKare, LLC | 42291-0183-50 | 500 | 74.40 | 0.14880 | 2023-06-15 - 2028-06-14 | FSS |
| BUPROPION HCL 300MG 24HR TAB,SA | AvKare, LLC | 42291-0183-30 | 30 | 3.96 | 0.13200 | 2023-06-15 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for the Drug NDC: 42291-0183
Understanding the National Drug Code (NDC)
To analyze the market and price projections for a specific drug identified by its NDC number (42291-0183), it is essential to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. This code is used in the FDA's National Drug Code Directory, which contains information on active and certified finished and unfinished drugs submitted by labelers[1][5].
Identifying the Drug
The NDC number 42291-0183 can be broken down into three segments: the labeler code, the product code, and the package code. By referencing the FDA's NDC Directory, one can identify the specific drug product associated with this NDC number. This directory includes details such as the drug's name, its active ingredients, dosage form, and packaging information[1][5].
Regulatory Environment
The regulatory environment plays a significant role in shaping drug pricing. Programs like Oregon's Drug Price Transparency Program require manufacturers to report price increases and new high-cost drugs, providing transparency into the factors driving price changes. Health insurers are also subject to regulatory oversight, which can influence pricing strategies and market dynamics[2].
Impact of Transparency Programs
Transparency programs, such as Oregon's, have shown that the quality of information submitted by manufacturers can be highly variable. This variability can make it challenging to determine the exact reasons for price increases. However, these programs do highlight significant price changes, such as the 2,527% increase for a generic naproxen manufactured by Hikma Pharmaceuticals between 2012 and 2021[4].
Market Competition
Competition from generic drugs and biosimilars is a critical factor in the life sciences industry. Nearly 37% of C-suite executives view competition from these alternatives as a top trend, which can significantly impact pricing strategies and market dynamics. As generic and biosimilar versions of branded drugs enter the market, they often drive down prices due to increased competition[2][3].
Generic and Biosimilar Impact
For the drug associated with NDC 42291-0183, if it is a branded drug, the introduction of generic or biosimilar versions could lead to significant price reductions. For instance, the median price increase for generic drugs was 19.9% in 2022, while for brand name drugs it was 13.4%. These figures indicate that generics and biosimilars can exert downward pressure on prices[2][4].
Patent Expirations
The looming patent cliff, with over $300 billion in sales at risk through 2030 due to expiring patents on high-revenue products, is another significant factor. This can lead to increased competition from generics and biosimilars, potentially affecting the pricing of branded drugs. Companies are likely to see increased interest in mergers and acquisitions to mitigate these losses[2][3].
Strategic Responses to Patent Expirations
Pharmaceutical companies facing patent expirations may engage in various strategies, such as developing new therapeutic classes, investing in research and development, or acquiring other companies to maintain market share and revenue. These strategies can influence the pricing dynamics of the drug market[3].
Overall Market Trends
For the period between January 1, 2025, and December 31, 2025, the Vizient Pharmacy Market Outlook projects a 0.00% overall drug price inflation rate. This suggests a stable pricing environment, but it does not account for individual drug price fluctuations. Specific drugs can still experience significant price changes based on various factors such as competition, regulatory actions, and market demand[2].
Specific Drug Price Projections
Without specific data on the drug associated with NDC 42291-0183, it is challenging to provide precise price projections. However, here are some general insights:
Generic and Brand Name Drugs
If the drug is a generic, it might experience price increases similar to those reported in Oregon's transparency program. For brand name drugs, the median price increase was 13.4% in 2022. These figures provide a baseline for understanding potential price movements[2][4].
Innovative Therapies
If the drug is part of a new therapeutic class, such as gene therapies or GLP-1 drugs, it may command higher prices due to its innovative nature and the value it brings to patients. These drugs often have unique pricing strategies that reflect their groundbreaking therapeutic benefits[3].
Case Studies and Examples
Extreme Price Increases
The case of a generic naproxen manufactured by Hikma Pharmaceuticals, which saw a 2,527% price increase from $34.13 in 2012 to $896.44 in 2021, highlights the potential for significant price volatility in the pharmaceutical market. Such extreme price increases are often driven by market dynamics, regulatory changes, and supply chain disruptions[2][4].
Regulatory Impact
Oregon's implementation of an upper payment limit for certain drugs, although not yet enforced, could set a precedent for state-level price controls. This could influence pricing strategies for drugs across different states, as companies may need to adjust their pricing to comply with varying state regulations[2].
Future Trends in the Pharmaceutical Industry
The pharmaceutical industry is undergoing significant transformations driven by trends such as prevention, personalization, prediction, and point of care. These trends are shifting the focus towards data-driven, customized treatments and more accessible care delivery models. Here’s how these trends might impact the drug associated with NDC 42291-0183:
Prevention and Personalization
As the industry moves towards prevention and personalization, drugs that offer tailored therapeutic benefits may see increased demand and potentially higher prices. Data-driven treatments based on genetics and behavior could become more prevalent, influencing the pricing and market positioning of drugs like the one associated with NDC 42291-0183[3].
Prediction and Point of Care
Advanced analytics and early intervention strategies could improve health outcomes and reduce the need for costly treatments. This shift towards predictive healthcare and more convenient care delivery models may affect the pricing and usage patterns of various drugs, including the one identified by NDC 42291-0183[3].
Key Takeaways
- NDC Understanding: The NDC is crucial for identifying and analyzing drugs, providing detailed information through the FDA's NDC Directory.
- Regulatory Impact: Transparency programs and regulatory oversight significantly influence drug pricing and market dynamics.
- Market Competition: Generic and biosimilar competition can drive down prices of branded drugs.
- Patent Expirations: The looming patent cliff can lead to increased competition and strategic responses from pharmaceutical companies.
- Future Trends: The industry is shifting towards prevention, personalization, prediction, and point of care, which could impact the pricing and market positioning of drugs.
FAQs
What is the National Drug Code (NDC) and how is it used?
The National Drug Code (NDC) is a unique three-segment number used by the FDA to identify drugs. It is used in the FDA's NDC Directory to provide detailed information about finished and unfinished drugs, including their active ingredients, dosage form, and packaging[1][5].
How do transparency programs affect drug pricing?
Transparency programs, such as Oregon's Drug Price Transparency Program, require manufacturers to report price increases and new high-cost drugs, providing transparency into the factors driving price changes. This can influence pricing strategies and market dynamics by highlighting significant price changes and regulatory actions[2][4].
What impact do generic and biosimilar drugs have on the market?
Generic and biosimilar drugs can significantly drive down the prices of branded drugs by increasing competition. The introduction of these alternatives often leads to reduced prices for the original branded drugs[2][3].
How do patent expirations affect pharmaceutical companies?
Patent expirations can lead to increased competition from generics and biosimilars, potentially affecting the pricing of branded drugs. Companies may engage in mergers and acquisitions or develop new therapeutic classes to mitigate these losses[2][3].
What are the future trends shaping the pharmaceutical industry?
The industry is moving towards trends such as prevention, personalization, prediction, and point of care. These trends involve data-driven treatments, early intervention, and more accessible care delivery models, which could impact the pricing and market positioning of drugs[3].
Sources
- Drug Patent Watch: Market Analysis and Price Projections for the Drug NDC: 42291-0779[1].
- Drug Patent Watch: Market Analysis and Price Projections for the Drug NDC: 42291-0819[2].
- PwC: Pharma industry trends: Five transformative trends shaping 2025 and beyond[3].
- Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Results and Recommendations[4].
- FDA: National Drug Code Directory[5].
More… ↓
